There is no doubt that the advancement of medical technology is a very expensive business. Research into new drugs by the 10 biggest drug companies in 2013, for example, exceeded $66 billion in brand-new spending. That’s a whole lot of money that their investors and shareholders are willing to risk for the NEXT big drug. And this level of investment has actually been growing for about 20 years straight — even more so lately, as global capital is chasing its way into the United States looking for a strong return. A really strong target for this capital is the U.S. pharmaceutical industry.
“As I look back over my life, I realize a few things about a lifetime of being overweight.”
Since 2009, I’ve given more than 800 presentations in Louisiana alone on healthcare reform and cost trends. Almost all of these were to business audiences, whose benefit offerings have been drastically affected by healthcare reform.
Straight Talk denizen Mike Bertaut is taking a break this week and letting his editors speak about a project close to their hearts – clear communication.
The trickle started slowly, with just a couple of relatives.
On Aug. 28, 2005, I, my wife and our three kids began to get some company. First, we had the five of us plus a mother-in-law. Then, my brother-in-law, his wife and two more kids came to stay. Then, the brother-in-law’s wife’s sister, her husband and her grandmother showed up. Then, the brother-in-law’s wife’s sister’s husband’s parents, grandparents, sister and family arrived. They just kept coming until there were 23 of them! People I had never met before had filled our house. We didn’t turn anyone away. I’ve lived in Louisiana my entire life, all 54 years, and that’s how we do it here. This is Our Home.
Blue Cross is looking at the public healthcare policy statements presidential candidates are making and Straight Talk’s Mike Bertaut will shed some light on the realities of some of these policies from his own perspective.